Login / Signup

Tissue-resident CD8 + T cells drive compartmentalized and chronic autoimmune damage against CNS neurons.

David FrieserAurora PignataLeila KhajaviDanielle ShlesingerCarmen Gonzalez-FierroXuan-Hung NguyenAlexander YermanosDoron MerklerRomana HöftbergerVirginie DesestretKatharina M MairJan BauerFrederick MassonRoland S Liblau
Published in: Science translational medicine (2022)
The mechanisms underlying the chronicity of autoimmune diseases of the central nervous system (CNS) are largely unknown. In particular, it is unclear whether tissue-resident memory T cells (T RM ) contribute to lesion pathogenesis during chronic CNS autoimmunity. Here, we observed that a high frequency of brain-infiltrating CD8 + T cells exhibit a T RM -like phenotype in human autoimmune encephalitis. Using mouse models of neuronal autoimmunity and a combination of T single-cell transcriptomics, high-dimensional flow cytometry, and histopathology, we found that pathogenic CD8 + T cells behind the blood-brain barrier adopt a characteristic T RM differentiation program, and we revealed their phenotypic and functional heterogeneity. In the diseased CNS, autoreactive tissue-resident CD8 + T cells sustained focal neuroinflammation and progressive loss of neurons, independently of recirculating CD8 + T cells. Consistently, a large fraction of autoreactive tissue-resident CD8 + T cells exhibited proliferative potential as well as proinflammatory and cytotoxic properties. Persistence of tissue-resident CD8 + T cells in the CNS and their functional output, but not their initial differentiation, were crucially dependent on CD4 + T cells. Collectively, our results point to tissue-resident CD8 + T cells as essential drivers of chronic CNS autoimmunity and suggest that therapies targeting this compartmentalized autoreactive T cell subset might be effective for treating CNS autoimmune diseases.
Keyphrases